Related references
Note: Only part of the references are listed.Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
Richard A. Rudick et al.
ANNALS OF NEUROLOGY (2010)
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease
Gionata Fiorino et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
David B. Clifford et al.
LANCET NEUROLOGY (2010)
Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
Wendy S. Putnam et al.
TRENDS IN BIOTECHNOLOGY (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases (vol 9, pg 438, 2010)
D. B. Clifford et al.
LANCET NEUROLOGY (2010)
A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis
Dan Turner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Conventional treatment in inflammatory bowel disease- recent trends. Immunosuppressants and biologic agents: should they or need they to be used together?
Y. Leung et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2009)
Biological Therapies for Inflammatory Bowel Diseases
Paul Rutgeerts et al.
GASTROENTEROLOGY (2009)
Immunotoxicity profile of natalizumab
Nancy G. Wehner et al.
JOURNAL OF IMMUNOTOXICOLOGY (2009)
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-alpha(4)beta(7) Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
Dulce Soler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Use of the Noninvasive Components of the Mayo Score to Assess Clinical Response in Ulcerative Colitis
James D. Lewis et al.
INFLAMMATORY BOWEL DISEASES (2008)
Natalizumab for the treatment of active Crohn's disease: Results of the ENCORE trial
Stephan R. Targan et al.
GASTROENTEROLOGY (2007)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The immunology of inflammatory bowel disease
S Plevy
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2002)
A new fecal calprotectin test for colorectal neoplasia - Clinical results and comparison with previous method
B Johne et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
